During the past decade, Complejo Hospitalario León conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario León" #1 sponsor was "PETHEMA Foundation" with 8 trials, followed by "Castilla-León Health Service" with 2 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 2 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored and "Asociación Española de Fabricantes y Distribuidores de Productos de Nutrición Enteral" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario León" #1 collaborator was "TFS Trial Form Support" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario León" are "Acute Lymphoblastic Leukemia" (4 trials), "Acute Promyelocytic Leukemia" (2 trials), "Multiple Myeloma" (2 trials), "Perioperative Care" (2 trials) and "Postoperative Complications" (2 trials). Many other conditions were trialed in "Complejo Hospitalario León" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario León" are "Drug" (13 trials), "Procedure" (3 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (4 trials), "Cyclophosphamide" (3 trials), "Daunorubicin" (3 trials), "Dexamethasone" (3 trials) and "Mercaptopurine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario León" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Complejo Hospitalario León". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Complejo Hospitalario León, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario León, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".